Search Results - "Gudyrev, O S"

  • Showing 1 - 20 results of 20
Refine Results
  1. 1

    Study of Endothelio- and Osteoprotective Effects of Combination of Rosuvastatin with L-Norvaline in Experiment by Chernomortseva, E. S., Anikanov, A. V., Dubrovin, G. M., Rajkumar, D. S. R., Gudyrev, O. S., Faitelson, A. V., Sobolev, M. S., Koklina, N. U.

    Published in Journal of osteoporosis (01-01-2018)
    “…The experiment was carried out on 120 female white Wistar rats, to study the endothelio- and osteoprotective action of the combination of rosuvastatin with…”
    Get full text
    Journal Article
  2. 2

    Comparative Evaluation of Enalapril and Losartan in Pharmacological Correction of Experimental Osteoporosis and Fractures of Its Background by Rajkumar, D. S. R., Faitelson, A. V., Gudyrev, O. S., Dubrovin, G. M., Pokrovskiy, Mihail V., Ivanov, A. V.

    Published in Journal of osteoporosis (01-01-2013)
    “…In the experiment on the white Wistar female rats (222 animals), the osteoprotective effect of enalapril and losartan was studied on experimental models of…”
    Get full text
    Journal Article
  3. 3

    APPswe/PS1dE9/Blg Transgenic Mouse Line for Modeling Cerebral Amyloid Angiopathy Associated with Alzheimer's Disease by Lysikova, E A, Kuzubova, E V, Radchenko, A I, Patrakhanov, E A, Chaprov, K D, Korokin, M V, Deykin, A V, Gudyrev, O S, Pokrovskii, M V

    Published in Molekuliarnaia biologiia (01-01-2023)
    “…Alzheimer's disease (AD) is the most common proteinopathy, which is accompanied by a steady decrease in the patient's cognitive functions with a simultaneous…”
    Get more information
    Journal Article
  4. 4

    APPswe/PS1dE9/Blg Transgenic Mouse Line for Modeling Cerebral Amyloid Angiopathy Associated with Alzheimer’s Disease by Lysikova, E. A., Kuzubova, E. V., Radchenko, A. I., Patrakhanov, E. A., Chaprov, K. D., Korokin, M. V., Deykin, A. V., Gudyrev, O. S., Pokrovskii, M. V.

    Published in Molecular biology (New York) (01-02-2023)
    “…Alzheimer’s disease (AD) is the most common proteinopathy, which is accompanied by a steady decrease in the patient’s cognitive functions with a simultaneous…”
    Get full text
    Journal Article
  5. 5

    Study of Endothelial Protective Activity of Phenol-Derived Thrombin and Arginase-2 Inhibitors KUD-259 and KUD-974 by Pokrovskii, M. V., Korokin, M. V., Kudryavtsev, K. V., Pokrovskaya, T. G., Gudyrev, O. S., Gureev, V. V., Korokina, L. V., Povetkin, S. V.

    “…We performed correction of endothelial dysfunction with phenol derivatives KUD-259 and KUD-974 containing heteroatomic and heterocyclic structures…”
    Get full text
    Journal Article
  6. 6
  7. 7

    CONVENTIONAL APPROACHES TO THE THERAPY OF HEREDITARY MYOPATHIES by Pokrovsky, M. V., Korokin, M. V., Krayushkina, A. M., Zhunusov, N. S., Lapin, K. N., Soldatova, M. O., Kuzmin, E. A., Gudyrev, O. S., Kochkarova, I. S., Deikin, A. V.

    Published in Farmaciâ i Farmakologiâ (Pâtigorsk) (01-01-2022)
    “…The aim of the work was to analyze the available therapeutic options for the conventional therapy of hereditary myopathies. Materials and methods. When…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10

    A Model of Hyperhomocysteine-Induced Endothelial Dysfunction in Rats by Korokin, M. V., Pokrovskiy, M. V., Novikov, O. O., Gudyrev, O. S., Gureev, V. V., Denisyuk, T. A., Korokina, L. V., Danilenko, L. M., Ragulina, V. A., Konovalova, E. A., Belous, A. S.

    “…Intragastric methionine (3 g/kg daily for 7 days) elevates homocysteine concentration and increases the endothelial dysfunction coefficient. This protocol of…”
    Get full text
    Journal Article
  11. 11

    Comparative evaluation of the osteoprotective effects of resveratrol and resveratrol/enalapril combination in the treatment of experimental osteoporosis by Faĭtel'son, A V, Koklina, N Iu, Gudyrev, O S, Dubrovin, G M, Pokrovskiĭ, M V, Ivanov, A V

    “…The osteoprotective effect of resveratrol and a combination of resveratrol with enalapril has been investigated in white Wistar female rats with experimental…”
    Get more information
    Journal Article
  12. 12
  13. 13

    STUDY OF ENDOTHELIAL PROTECTIVE AND OSTEOPROTECTIVE PROPERTIES OF ROSUVASTATIN, L-NORVALINE AND THEIR COMBINATIONS IN EXPERIMENTAL OSTEOPOROSIS by SOBOLEV, M. S., FAITELSON, A. V., GUDYREV, O. S., RAJKUMAR, D. S. R., DUBROVIN, G. M., MYAGKIH, V. I.

    “…Aim. Study of the effectiveness of pharmacological management of experimental osteoporosis with rosuvastatin, L-norvaline and their combination in comparison…”
    Get full text
    Journal Article
  14. 14

    Correction of endothelial dysfunction by L-arginine under experimental pre-eclampsia conditions by Pokrovskiĭ, M V, Pokrovskaia, T G, Gureev, V V, Barsuk, A A, Proskuriakova, E V, Korokin, M V, Gudyrev, O S, Belous, A S, Kochkarov, V I, Danilenko, L M, Levashova, O V, Mal'tseva, N V, Polianskaia, O S

    “…The ADMA-like pre-eclampsia in pregnant rats was modeled by daily introduction of L-NAME in a dose of 25 mg/kg for 7 days. L-arginine (200 mg/kg) prevented the…”
    Get more information
    Journal Article
  15. 15

    Pharmacological correction of experimental chronic limb ischemia by Artiushkova, E B, Pashkov, D V, Pokrovskiĭ, M V, Faĭtel'son, A V, Gudyrev, O S, Pokrovskaia, T G, Pashin, E N, Kochkarov, V I

    “…In tests on a group of 250 rats, we studied (i) the level of microcirculation in the muscles of a healthy limb in the norm and (ii) the dynamics of…”
    Get more information
    Journal Article
  16. 16

    Study of the mechanisms cardioprotektive effect of 3-(2,2,2- trimethylhydrazinium) propionate by L. M. Danilenko, M. V. Pokrovsky, M. V. Korokin, O. S. Gudyrev

    “…The work evaluated the influence of 3-(2,2,2-trimethylhydrazinium) propionate per square necrotic myocardium of the left ventricle and the level troponina I…”
    Get full text
    Journal Article
  17. 17

    The study of antiosteoporotic action of nanoparticulated resveratrol and losartan by N. U. Koklina, O. S. Gudyrev, A. V. Faitelson, M. V. Pokrovskiy

    “…The study demonstrated that eight weeks after ovariectomy in female white Wistar rats endothelial dysfunction of bone microvasculature and deterioration of…”
    Get full text
    Journal Article
  18. 18

    Correction of endotoxin-induced endothelial dysfunction by recombinant erythropoetin and inhibitors of HMG-Co-A-reductase by T. A. Denisyuk, M. V. Pokrovsky, T. G. Pokrovskaya, M. V. Korokin, O. S. Gudyrev, K. M. Reznikov, S. V. Povetkin, A. A. Stepchenko

    “…Using the combined use of recombinant erythropoietin «Darbopoetin alpha» (500 mcg / kg) with simvastatin, atorvastatin, rosuvastatin and rosuvastatin…”
    Get full text
    Journal Article
  19. 19

    Endotelioand cardioprotective effects of HMG-Co-A reductase in endotoksininducing endotelial dysfunction by T. A. Denisuk, M. V. Pokrovskii, O. V. Philippova, O. S. Gudyrev, T. G. Pokrovskaya, M. V. Korokin, O. A. Osipova

    “…The use of inhibitors of HMG-Co-A reductase inhibitor simvastatin, atorvastatin, rosuvastatin and nanoparticulative rosuvastatin on background modeling…”
    Get full text
    Journal Article
  20. 20

    ENDOTHELIOPROTECTIVE AND CARDIOPROTECTIVE ACTIVITY OF SELECTIVE ARGINASE II INHIBITOR by V. I. Yakushev, V. V. Gureev, M. V. Pokrovskii, M. V. Korokin, O. S. Gudyrev, T. G. Pokrovskaya, E. A. Beskhmelnitsyna, A. S. Litvinova, V. V. Elagin

    “…They researched endothelioprotective and cardioprotective activity of arginase II selective inhibitor (substance code ZB49-0010C) in model of L-NAME-induced…”
    Get full text
    Journal Article